Home Tools
Log in
Cart

Search Result

Search Results for " nvp-2 "

16

Compounds

Cat No. Product Name Synonyms Targets
T16363 NVP-2 Apoptosis , CDK
NVP-2 is an effective and selective ATP-competitive cyclin-dependent kinase 9 (CDK9) probe. NVP-2 induces cell apoptosis. NVP-2 inhibits CDK9/CycT activity (IC50: 0.514 nM). NVP-2 shows inhibitory effcts on CDK1/CycB, CD...
T1918 NVP-TAE 226 TAE226 Apoptosis , FAK , c-Met/HGFR , PYK2 , IGF-1R
NVP-TAE 226 (TAE226) is an effective FAK inhibitor (IC50: 5.5 nM) and most effective to Pyk2(IC50: 3.5 nM); 10- to 100-fold less effective against IGF-1R, InsR, c-Met, and ALK.
TQ0231 NVP-CGM097 CGM097 Mdm2 , E1/E2/E3 Enzyme
NVP-CGM097 (CGM097) is an effective and specific MDM2 inhibitor (IC50: 1.7 nM for hMDM2).
T5555 Siremadlin NVP-HDM 201 E1/E2/E3 Enzyme
Siremadlin (NVP-HDM 201) is a potent, orally bioavailable and highly specific p53-MDM2 interaction inhibitor.
T1502 Vildagliptin NVP-LAF 237,LAF237 Apoptosis , Ferroptosis , Proteasome , DPP-4
Vildagliptin (LAF237) is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiety undergoes hydrolysis and this inactive metabolit...
T2235 Dactolisib BEZ235,NVP-BEZ235 ATM/ATR , PI3K , mTOR , Autophagy
Dactolisib (BEZ235) is an orally bioavailable inhibitor of PI3K and mTOR (IC50s: 4 nM/5 nM/7 nM/75 nM, and 20.7 nM for p110α/p110γ/p110δ/p110β and mTOR).
T2251 NVP-TAE 684 TAE684 Apoptosis , ALK
NVP-TAE 684 (TAE684) is a excellently effective and specific ALK inhibitor(IC50=3 nM).
T33763 NVP CXCR2 20 NVP-CXCR2 20,NVP CXCR2-20,NVP CXCR220
NVP CXCR2 20 is an effective selective CXCR2 antagonist (IC50 = 40 nM) with oral bioavailability.
T5049 NVP-BSK805 NVP-BSK805 2HCl,BSK 805 Tyrosine Kinases , JAK
NVP-BSK805 (BSK 805) is an ATP-competitive JAK2 inhibitor.
T3463 NVP-ACC789 ACC-789,ZK202650 VEGFR , PDGFR
ACC-789 (NVP-ACC789 (ZK202650); ZK-202650) is an effective, specific and orally active inhibitor of the VEGF receptor tyrosine kinases.
T1975 Infigratinib BGJ-398,NVP-BGJ398 Apoptosis , FGFR
Infigratinib (NVP-BGJ398) (BGJ398) is an orally bioavailable pan FGFR inhibitor (IC50: 0.9/1.4/1 nM for FGFR1/2/3), >40-fold selective for FGFR versus FGFR4 and VEGFR2.
T1933 NVP 231 Apoptosis , ERK
NVP-231 is a potent, specific and reversible CerK inhibitor(IC50=12±2 nM) that competitively inhibits ceramide binding to CerK.
T2116 AEE788 NVP-AEE 788 Apoptosis , EGFR , c-Fms , FLT , Bcr-Abl
AEE788 (NVP-AEE 788) has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors.
T6079 NVP-ADW742 ADW742,ADW,GSK 552602A Apoptosis , IGF-1R
NVP-ADW742 (ADW) is an IGF-1R inhibitor with IC50 of 0.17 μM, >16-fold more potent against IGF-1R than InsR; little activity to HER2, PDGFR, VEGFR-2, Bcr-Abl and c-Kit.
T25894 NVP-AAD777 AAD-777,NVP-AAD-777,NVP AAD 777
NVP-AAD777 is a specific VEGFR-2 inhibitor.
T74717 12-Hydroxynevirapine
12-Hydroxynevirapine (12-hydroxy-NVP; 12-OH-NVP), a significant oxidative metabolite of Nevirapine—an antiviral drug used for HIV-1 infections known for potential idiosyncratic hepatotoxicity and skin rashes—undergoes bi...
TargetMol